EPZM insider filings

Epizyme, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-08-16. Screen EPZM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for EPZM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Epizyme, Inc.

FiledFormInsiderReported transactionsSource
2022-08-164Giordano Michael F — DirectorDisposition to issuer (D): 8,060 · Disposition to issuer (D): 8,994EDGAR
2022-08-164Richon Victoria — DirectorDisposition to issuer (D): 13,614 · Disposition to issuer (D): 8,994EDGAR
2022-08-164BEVERIDGE, ROY A — DirectorDisposition to issuer (D): 20,341 · Disposition to issuer (D): 25,696EDGAR
2022-08-164Agarwal ShefaliDisposition to issuer (D): 179,247 · Disposition to issuer (D): 107,292EDGAR
2022-08-164Korn Jerald — Chief Operating OfficerHoldings only — no transactions reportedEDGAR
2022-08-164Beaulieu Joseph — See RemarksDisposition to issuer (D): 30,181 · Disposition to issuer (D): 21,895EDGAR
2022-08-164Kutok Jeffery — Chief Scientific OfficerDisposition to issuer (D): 39,046 · Disposition to issuer (D): 81,021EDGAR
2022-08-164Stuckley Carol — DirectorDisposition to issuer (D): 25,696EDGAR
2022-08-164Bogle Grant C. — President and CEO, DirectorDisposition to issuer (D): 84,170 · Disposition to issuer (D): 175,000EDGAR
2022-08-164Legorreta Pablo G. — Director, 10% owner
RP Management, LLC — Director, 10% owner
RPI Finance Trust — Director, 10% owner
Royalty Pharma Investments 2019 ICAV — Director, 10% owner
Code (U): 31,933,334 · Disposition to issuer (D): 8,060 (derivative) @ $0 · Disposition to issuer (D): 8,994 (derivative) @ $0EDGAR
2022-08-164Conroy Kevin T — DirectorDisposition to issuer (D): 53,324 · Disposition to issuer (D): 8,994EDGAR
2022-08-164MOTT DAVID M — DirectorCode (U): 215,494 · Disposition to issuer (D): 8,994 · Code (U): 106,959EDGAR
2022-08-164BATE KENNETH — DirectorDisposition to issuer (D): 8,060 · Disposition to issuer (D): 8,994EDGAR
2022-08-164GOLDFISCHER CARL — DirectorDisposition to issuer (D): 13,060 · Disposition to issuer (D): 8,994 · Disposition to issuer (D): 3,380,951EDGAR
2022-08-114Bogle Grant C. — See Remarks, DirectorOption exercise (M): 800,000 @ $1.39 · Tax withholding (F): 746,307 @ $1.39 · Option exercise (M): 417,500 @ $1.41 · Tax withholding (F): 395,083 @ $1.41 · Option exercise (M): 800,000 (derivative) @ $0 · Option exercise (M): 417,500 (derivative) @ $0EDGAR
2022-08-114Agarwal ShefaliOption exercise (M): 56,527 @ $1.39 · Option exercise (M): 43,473 @ $1.39 · Option exercise (M): 400,000 @ $1.39 · Tax withholding (F): 373,154 @ $1.39 · Option exercise (M): 56,527 (derivative) @ $0 · Option exercise (M): 43,473 (derivative) @ $0 · +1 moreEDGAR
2022-08-114Beaulieu Joseph — See RemarksOption exercise (M): 300,000 @ $1.39 · Tax withholding (F): 279,864 @ $1.39 · Option exercise (M): 300,000 (derivative) @ $0EDGAR
2022-08-114Kutok Jeffery — Chief Scientific OfficerOption exercise (M): 380,000 @ $1.39 · Tax withholding (F): 354,496 @ $1.39 · Option exercise (M): 380,000 (derivative) @ $0EDGAR
2022-07-054BEVERIDGE, ROY A — DirectorGrant/award (A): 8,928 @ $1.47EDGAR
2022-07-054Conroy Kevin T — DirectorGrant/award (A): 10,204 @ $1.47EDGAR
2022-07-054MOTT DAVID M — DirectorGrant/award (A): 16,156 @ $1.47EDGAR
2022-05-194Richon Victoria — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194Stuckley Carol — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194Giordano Michael F — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194BEVERIDGE, ROY A — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194Legorreta Pablo G. — Director, 10% owner
RP Management, LLC — Director, 10% owner
RPI Finance Trust — Director, 10% owner
Royalty Pharma Investments 2019 ICAV — Director, 10% owner
Grant/award (A): 41,006 (derivative) @ $0.56 · Grant/award (A): 8,994 (derivative) @ $0EDGAR
2022-05-194Conroy Kevin T — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194MOTT DAVID M — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194BATE KENNETH — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-05-194GOLDFISCHER CARL — DirectorGrant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-04-134Kutok Jeffery — Chief Scientific OfficerSale (S): 2,741 @ $0.90EDGAR
2022-04-044Korn Jerald — Chief Operating OfficerGrant/award (A): 800,000 (derivative) @ $0EDGAR
2022-04-014BEVERIDGE, ROY A — DirectorGrant/award (A): 11,413 @ $1.15EDGAR
2022-04-014Conroy Kevin T — DirectorGrant/award (A): 13,043 @ $1.15EDGAR
2022-04-014MOTT DAVID M — DirectorGrant/award (A): 20,653 @ $1.15EDGAR
2022-03-214Bogle Grant C. — See Remarks, DirectorGrant/award (A): 800,000 (derivative) @ $0EDGAR
2022-03-214Beaulieu Joseph — See RemarksGrant/award (A): 2,331 @ $1.27 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2022-03-214Kutok Jeffery — Chief Scientific OfficerGrant/award (A): 380,000 (derivative) @ $0EDGAR
2022-03-214Agarwal Shefali — See RemarksGrant/award (A): 2,331 @ $1.27 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2022-02-094Beaulieu Joseph — Corporate ControllerSale (S): 222 @ $1.50EDGAR
2022-02-094Agarwal Shefali — See RemarksSale (S): 1,058 @ $1.50EDGAR
2022-02-044Agarwal Shefali — See RemarksSale (S): 2,639 @ $1.37EDGAR
2022-02-044Bogle Grant C. — See Remarks, DirectorGrant/award (A): 87,500 @ $0 · Grant/award (A): 417,500 (derivative) @ $0EDGAR
2022-02-044Kutok Jeffery — Chief Scientific OfficerSale (S): 2,556 @ $1.37EDGAR
2022-02-044Beaulieu Joseph — Corporate ControllerSale (S): 687 @ $1.37EDGAR
2022-02-014Legorreta Pablo G. — Director, 10% owner
RP Management, LLC — 10% owner
RPI Finance Trust — 10% owner
Purchase (P): 22,666,667 @ $1.50EDGAR
2022-01-284Agarwal Shefali — See RemarksSale (S): 2,922 @ $2.02EDGAR
2022-01-044Conroy Kevin T — DirectorGrant/award (A): 6,000 @ $2.50EDGAR
2022-01-044MOTT DAVID M — DirectorGrant/award (A): 9,500 @ $2.50EDGAR
2021-12-074Agarwal Shefali — See RemarksSale (S): 1,780 @ $2.93EDGAR

Recent 8-K events — Epizyme, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-08-128-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-06-278-K1.01 — Entry into a Material Definitive Agreement
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2022-05-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-04-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-03-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-018-K2.02 — Results of Operations and Financial Condition
?
9.01 — Financial Statements and Exhibits
EDGAR
2022-01-278-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EPZM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs